1198444
1206367
1206379
H3D Vision & Mission
Vision: To be the leading organisation for integrated drug discovery and development on the African continent Mission: Discover and develop innovative, life saving medicines For African patients Through excellence in interdisciplinary,...
H3D Facilities
Facilities H3D has state of the art laboratory equipment and access to modern instrumentation housed in the Department of Chemistry, the Department of Clinical Pharmacology and the Institute of Infectious Disease and Molecular Medicine (IDM) at UCT...
R&D Environment
UCT offers a truly integrated environment for translational research in communicable and non communicable diseases afflicting people in Africa. It has both the infrastructure as well as numerous groups working on pre-clinical and clinical research...
Home > Home

News

Thursday, 15 November 2018
GRAND CHALLENGES MEETING

Prof Kelly Chibale participated in the Bill and Melinda Gates Foundation's Grand Challenges meeting held in Berlin, Germany from 15-18 October 2018 and gave a Spotlight talk.  

Publication Date:
Wednesday, October 24, 2018 - 14:00
PRACTICAL ASPECTS OF DRUG DISCOVERY
Learn about the theoretical, practical and organisational aspects of small molecule and natural product drug discovery.
Publication Date:
Friday, June 29, 2018 - 14:00
UCT KEY IN NEW DRUGS SEARCH
The University of Cape Town’s Drug Discovery and Development Centre (H3D) will be pivotal in a new international drug discovery programme aimed at financing not only the identification of new drug candidates to combat diseases such as malaria and tuberculosis, but also the development of African scientists.
Publication Date:
Friday, June 29, 2018 - 14:00
OPEN CALL FOR LETTER OF INTENT (LOI) ON DRUG DISCOVERY
1. Background

Drug discovery excellence is a critical prerequisite for success in drug development and remains a highly neglected area for the African continent. The lack of market incentives has biased drug discovery efforts globally away from diseases most prevalent in the developing world. Collaborative efforts of multidisciplinary teams – in drug discovery and other fields – shows that success and efficiency increases significantly when individual contributors combine their complementary capabilities. The whole is greater than the sum of its parts. State-of-the-art approaches to implementing drug discovery projects, especially when the goal is to also build drug discovery capability on the African continent, need to be supported.

Publication Date:
Monday, April 23, 2018 - 14:00

Pages